LoginRegister

    Cipla API facility in Bengaluru gets EIR from USFDA

    Medical Dialogues BureauWritten by Medical Dialogues Bureau   |  
    Cipla API facility in Bengaluru gets EIR from USFDA

    Cipla had earlier said that USFDA issued seven observations after conducting a routine 'CGMP inspection' at Cipla's API manufacturing facility in Virgonangar, Bengaluru.


    NEW DELHI: Cipla Ltd on Sunday announced the closure of inspection by the US health regulator at the company's API manufacturing facility in Bengaluru.


    "Following the inspection by the United States Food and Drug Administration (USFDA) at Company's API manufacturing facility in Virgonagar, Bengaluru, from July 15- 19, 2019, the company has received the Establishment Inspection Report (EIR), indicating closure of the inspection," the company said in a filing to the BSE.


    Read Also: Cipla arm, Novartis enter agreement for Ultibro Breezhaler to treat COPD


    The company had earlier said that USFDA issued seven observations after conducting a routine 'CGMP inspection' at Cipla's API manufacturing facility in Virgonangar, Bengaluru.


    Read Also: Cipla, Stempeutics ink licensing deal for Stempeucel-DFU to treat a diabetic foot ulcer

    APIBengaluru facilityCGMP inspectionCiplaCipla CGMP inspectionCipla VirgonagarEIREstablishment Inspection Reportpharmapharma companypharma newspharma news indiaUS health regulatorUSFDAUSFDA inspectionUSFDA observationsVirgonangar
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X